COVID-19 in congenital heart disease (COaCHeD) study

BACKGROUND: COVID-19 has caused significant worldwide morbidity and mortality. Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. OBJECTIVE: Ascertain the impact of COVID-19 on people with CHD and define...

Descripción completa

Detalles Bibliográficos
Autores principales: Chivers, Sian, Cleary, Aoife, Knowles, Rachel, Babu-Narayan, Sonya V, Simpson, John M, Nashat, Heba, Dimopoulos, Konstantinos, Gatzoulis, Michael A, Wilson, Dirk, Prica, Milos, Anthony, James, Clift, Paul F, Jowett, Victoria, Jenkins, Petra, Khodaghalian, Bernadette, Jones, Caroline B, Hardiman, Antonia, Head, Catherine, Miller, Owen, Chung, Natali AY, Mahmood, Umar, Bu'Lock, Frances A, Ramcharan, Tristan KW, Chikermane, Ashish, Shortland, Jennifer, Tometzki, Andrew, Crossland, David S, Reinhardt, Zdenka, Lewis, Clive, Rittey, Leila, Hares, Dominic, Panagiotopoulou, Olga, Smith, Benjamin, Najih L, Muhammad, Bharucha, Tara, Daubeney, Piers EF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Congenital Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357297/
https://www.ncbi.nlm.nih.gov/pubmed/37460271
http://dx.doi.org/10.1136/openhrt-2023-002356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357297/
https://www.ncbi.nlm.nih.gov/pubmed/37460271
http://dx.doi.org/10.1136/openhrt-2023-002356

Ejemplares similares